Lucio Quagliuolo

Lucio Quagliuolo

Auto-generated profile, based on publicly available information

Lucio Quagliuolo

Department of Biochemistry and Biophysics, Second University of Naples, Naples, Italy

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1990 in European Journal of Biochemistry
Verified
Journal Article
Closed access
PDF file
CBCiro Balestrieri
Ciro Balestrieri
DCDomenico Castaldo
Domenico Castaldo
AGAlfonso Giovane
Alfonso Giovane
LQLucio Quagliuolo
Lucio Quagliuolo
LSLuigi Servillo
Luigi Servillo

7 April 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
DVDaniela Vanacore
Daniela Vanacore
Mariarosaria BoccellinoMariarosaria Boccellino
Mariarosaria Boccellino
SRSABRINA ROSSETTI
SABRINA ROSSETTI
CCCarla Cavaliere
Carla Cavaliere
CDCarmine D’aNiello
Carmine D’aNiello
GFGAETANO FACCHINI
GAETANO FACCHINI
Micrornas in prostate cancer: an overview

1 August 2009 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
JCJeremy Chien
Jeremy Chien
TOTakayo Ota
Takayo Ota
GAGiovanni Aletti
Giovanni Aletti
RSRavi Shridhar
Ravi Shridhar
Mariarosaria BoccellinoMariarosaria Boccellino
Mariarosaria Boccellino
VSViji Shridhar
Viji Shridhar
HtrA1 belongs to a family of serine proteases found in organisms ranging from bacteria to humans. Bacterial HtrA1 (DegP) is a heat shock-induced protein that behaves as a chaperone at low temperature and as a protease at high temperature to help remove unfolded proteins during heat shock. In contrast to bacterial HtrA1, little is known about the function of human HtrA1. Here, we report the first evidence that human HtrA1 is a microtubule-associated protein and modulates microtubule stability and cell motility. Intracellular HtrA1 is localized to microtubules in a PDZ (PSD95, Dlg, ZO1) domain-dependent, nocodazole-sensitive manner. During microtubule assembly, intracellular HtrA associates with centrosomes and newly polymerized microtubules. In vitro, purified HtrA1 promotes microtubule assembly. Moreover, HtrA1 cosediments and copurifies with microtubules. Purified HtrA1 associates with purified alpha- and beta-tubulins, and immunoprecipitation of endogenous HtrA1 results in coprecipitation of alpha-, beta-, and gamma-tubulins. Finally, downregulation of HtrA1 promotes cell motility, whereas enhanced expression of HtrA1 attenuates cell motility. These results offer an original identification of HtrA1 as a microtubule-associated protein and provide initial mechanistic insights into the role of HtrA1 in the regulation of cell motility by modulating microtubule stability.

1 November 1995 in European Journal of Biochemistry
Verified
Journal Article
Closed access
PDF file
AGAlfonso Giovane
Alfonso Giovane
CBCiro Balestrieri
Ciro Balestrieri
LQLucio Quagliuolo
Lucio Quagliuolo
DCDomenico Castaldo
Domenico Castaldo
LSLuigi Servillo
Luigi Servillo

1 May 2021 in Endocrine, Metabolic & Immune Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
CICiro Gargiulo Isacco
Ciro Gargiulo Isacco
ABAndrea Ballini
Andrea Ballini
DANILA DE VITODANILA DE VITO
DANILA DE VITO
KNKieu Cao Diem Nguyen
Kieu Cao Diem Nguyen
SCStefania Cantore
Stefania Cantore
Francesco InchingoloFrancesco Inchingolo
Francesco Inchingolo
The current treatment and prevention of oral disorders follow a very sectoral control and procedures considering mouth and its structures as system completely independent from the rest of the body. The main therapeutic approach is carried out on just to keep the levels of oral bacteria and hygiene in an acceptable range compatible with one-way vision of oral-mouth health completely separated from a systemic microbial homeostasis (eubiosis vs dysbiosis). This can negatively impact on the diagnosis of more complex systemic disease and its progression. Dysbiosis is consequence of oral and gut microbiota unbalance with consequences, as reported in current literature, in cardio vascular disease, diabetes mellitus, rheumatoid arthritis, and Alzheimer’s disease. Likewise, there is the need to highlight and develop a novel philosophical approach in the treatments for oral diseases that will necessarily involve non-conventional approaches.

1 January 1990 in Phytochemistry
Verified
Journal Article
Closed access
AGA. Giovane
A. Giovane
LQL. Quagliuolo
L. Quagliuolo
DCD. Castaldo
D. Castaldo
LSL. Servillo
L. Servillo
CBC. Balestrieri
C. Balestrieri